Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)
Clinical trial NCT02157883 · COMPLETED
Trial details
- NCT number
- NCT02157883
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-06
- Primary completion
- 2015-04-03
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.